Nguyen Trong Vinh¹, Lam Thanh Hien¹, Ha Manh Toan², Ngo Duc Vinh³, Do Nang Toan^2,*

Intelligent Automation & Soft Computing, Vol.39, No.2, pp. 281-299, 2024, DOI:10.32604/iasc.2024.045297 - 21 May 2024

Abstract Tuberculosis is a dangerous disease to human life, and we need a lot of attempts to stop and reverse it. Significantly, in the COVID-19 pandemic, access to medical services for tuberculosis has become very difficult. The late detection of tuberculosis could lead to danger to patient health, even death. Vietnam is one of the countries heavily affected by the COVID-19 pandemic, and many residential areas as well as hospitals have to be isolated for a long time. Reality demands a fast and effective tuberculosis diagnosis solution to deal with the difficulty of accessing medical services,… More >

Ha Manh Toan¹, Lam Thanh Hien², Ngo Duc Vinh³, Do Nang Toan^1,*

CMC-Computers, Materials & Continua, Vol.74, No.3, pp. 5001-5016, 2023, DOI:10.32604/cmc.2023.033429 - 28 December 2022

Abstract Deep learning created a sharp rise in the development of autonomous image recognition systems, especially in the case of the medical field. Among lung problems, tuberculosis, caused by a bacterium called Mycobacterium tuberculosis, is a dangerous disease because of its infection and damage. When an infected person coughs or sneezes, tiny droplets can bring pathogens to others through inhaling. Tuberculosis mainly damages the lungs, but it also affects any part of the body. Moreover, during the period of the COVID-19 (coronavirus disease 2019) pandemic, the access to tuberculosis diagnosis and treatment has become more difficult, so… More >

Elyes Ben Salah¹, Karim Dorgham¹, Mylène Lesénéchal², Camille Pease², Laure Allard², Céline Dragonetti², Guy Gorochov¹, Amélie Guihot¹, Delphine Sterlin¹

European Cytokine Network, Vol.29, No.4, pp. 136-145, 2018, DOI:10.1684/ecn.2018.0417

Abstract Worldwide there are about 1.7 billion individuals with latent tuberculosis infection (LTBI) and only 5% to 15% will develop active tuberculosis (TB). It is recommended to treat only those most at risk of develop ing active TB to avoid problems of drug resistance. LTBI diagnosis involves reviewing the individual’s medical history, physical examination, and biological tests. Interferon gamma release assays (IGRA) can yield “undetermi nate” or “uncertain” results, which makes clinical management decisions difficult. We assessed an ultra-sensitive immunoassay prototype based on single molecule array (SiMoA) technology to evaluate its overall performance, and in particular,… More >